Cargando…

Circular RNAs in renal cell carcinoma: from mechanistic to clinical perspective

CircRNAs, a special type of noncoding RNAs characterized by their stable structure and unique abilities to form backsplicing loops, have recently attracted the interest of scientists. These RNAs are abundant throughout the body and play important roles such as microRNA sponges, templates for transcr...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chunjie, Esfani Sarafraz, Pooya, Enayati, Parisa, Mortazavi Mamaghani, Elham, Babakhanzadeh, Emad, Nazari, Majid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664289/
https://www.ncbi.nlm.nih.gov/pubmed/37993909
http://dx.doi.org/10.1186/s12935-023-03128-w
_version_ 1785148712386822144
author Huang, Chunjie
Esfani Sarafraz, Pooya
Enayati, Parisa
Mortazavi Mamaghani, Elham
Babakhanzadeh, Emad
Nazari, Majid
author_facet Huang, Chunjie
Esfani Sarafraz, Pooya
Enayati, Parisa
Mortazavi Mamaghani, Elham
Babakhanzadeh, Emad
Nazari, Majid
author_sort Huang, Chunjie
collection PubMed
description CircRNAs, a special type of noncoding RNAs characterized by their stable structure and unique abilities to form backsplicing loops, have recently attracted the interest of scientists. These RNAs are abundant throughout the body and play important roles such as microRNA sponges, templates for transcription, and regulation of protein translation and RNA-binding proteins. Renal cancer development is highly correlated with abnormal circRNA expression in vivo. CircRNAs are currently considered promising targets for novel therapeutic approaches as well as possible biomarkers for prognosis and diagnosis of various malignancies. Despite our growing understanding of circRNA, numerous questions remain unanswered. Here, we address the characteristics of circRNAs and their function, focusing in particular on their impact on drug resistance, metabolic processes, metastasis, cell growth, and programmed cell death in renal cancer. In addition, the application of circRNAs as prognostic and diagnostic biomarkers will be discussed.
format Online
Article
Text
id pubmed-10664289
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106642892023-11-22 Circular RNAs in renal cell carcinoma: from mechanistic to clinical perspective Huang, Chunjie Esfani Sarafraz, Pooya Enayati, Parisa Mortazavi Mamaghani, Elham Babakhanzadeh, Emad Nazari, Majid Cancer Cell Int Review CircRNAs, a special type of noncoding RNAs characterized by their stable structure and unique abilities to form backsplicing loops, have recently attracted the interest of scientists. These RNAs are abundant throughout the body and play important roles such as microRNA sponges, templates for transcription, and regulation of protein translation and RNA-binding proteins. Renal cancer development is highly correlated with abnormal circRNA expression in vivo. CircRNAs are currently considered promising targets for novel therapeutic approaches as well as possible biomarkers for prognosis and diagnosis of various malignancies. Despite our growing understanding of circRNA, numerous questions remain unanswered. Here, we address the characteristics of circRNAs and their function, focusing in particular on their impact on drug resistance, metabolic processes, metastasis, cell growth, and programmed cell death in renal cancer. In addition, the application of circRNAs as prognostic and diagnostic biomarkers will be discussed. BioMed Central 2023-11-22 /pmc/articles/PMC10664289/ /pubmed/37993909 http://dx.doi.org/10.1186/s12935-023-03128-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Huang, Chunjie
Esfani Sarafraz, Pooya
Enayati, Parisa
Mortazavi Mamaghani, Elham
Babakhanzadeh, Emad
Nazari, Majid
Circular RNAs in renal cell carcinoma: from mechanistic to clinical perspective
title Circular RNAs in renal cell carcinoma: from mechanistic to clinical perspective
title_full Circular RNAs in renal cell carcinoma: from mechanistic to clinical perspective
title_fullStr Circular RNAs in renal cell carcinoma: from mechanistic to clinical perspective
title_full_unstemmed Circular RNAs in renal cell carcinoma: from mechanistic to clinical perspective
title_short Circular RNAs in renal cell carcinoma: from mechanistic to clinical perspective
title_sort circular rnas in renal cell carcinoma: from mechanistic to clinical perspective
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664289/
https://www.ncbi.nlm.nih.gov/pubmed/37993909
http://dx.doi.org/10.1186/s12935-023-03128-w
work_keys_str_mv AT huangchunjie circularrnasinrenalcellcarcinomafrommechanistictoclinicalperspective
AT esfanisarafrazpooya circularrnasinrenalcellcarcinomafrommechanistictoclinicalperspective
AT enayatiparisa circularrnasinrenalcellcarcinomafrommechanistictoclinicalperspective
AT mortazavimamaghanielham circularrnasinrenalcellcarcinomafrommechanistictoclinicalperspective
AT babakhanzadehemad circularrnasinrenalcellcarcinomafrommechanistictoclinicalperspective
AT nazarimajid circularrnasinrenalcellcarcinomafrommechanistictoclinicalperspective